![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 28, 2021 12:21:59 PM
Sent: 23 September 2021 15:59
To: PCL <PCL@mhra.gov.uk>
Subject: Query about the Certification of the Sawston Facility.
Hi,
On May 12, Northwest Biotherapeutics (US Compagny) announced that they submitted an Application to MHRA for Certification of the Sawston Facility.
Registered office address:
Sawston Business Park, Sawston, Cambridge, United Kingdom, CB22 3JG
All of the development activities for the Sawston facility have been carried out under contract with Advent BioServices, who is also the operator of the facility.
My queries:
Is the GMP application filed under Advent Bioservices or Northwest Biotherapeutics?
Who will be the owner of the CERTIFICATE OF GMP COMPLIANCE? Northwest Biotherapeutics or Advent Bioservices?
Has Northwest Biotherapeutics or Advent Bioservices submitted an additional application for a Manufacturing and Importation Authorisation (MIA) and/or an MIA for investigational medicinal product (MIA IMP)?
We are now more than 90 working days after May 7, the day that the application package was submitted to the MHRA. When will the process of Regulatory Certification being completed?
Best,
XXXXXXX
Reply this morning:
Dear XXXXXX
Thanks for the enquiry below.
Yes, we have received an application for ADVENT BIOSERVICES LTD for an MIA(IMP) license.
Their application is still currently under assessment with an inspector.
Yes, initial application could take 90 working days or longer if further enquiries are required from company.
If you require further information, we advise you contact the company directly.
Kind Regards
Inspectorate & Process licensing (OA)
Inspection, Enforcement & Standards Division
Medicines and Healthcare Products Regulatory Agency
10th Floor, 10 South Colonnade, Canary Wharf, London, E14 4PU.
Telephone: 020 3080 6844
gov.uk/mhra
This afternoon:
Sent: 28 September 2021
To: PCL <PCL@mhra.gov.uk>
Subject: Re: Query about the Certification of the Sawston Facility.
Hi,
Thanks for the reply! Much appreciated!
I understand that the GMP application for the Sawston facility is still currently under assessment with an inspector.
I have a last question: Who will be the owner of the CERTIFICATE OF GMP COMPLIANCE of the manufacturing facility in Sawston?
Northwest Biotherapeutics, the owner of the facility in Sawston or Advent Bioservices, the CDMO who is also the operator of the facility?
Best,
XXXXXX
About 2 hours ago:
Best,
XXXXXX
Dear XXXXXX,
Thanks for the enquiry below.
The name of the company provided to us was ADVENT BIOSERVICES LTD which will be named on the GMP certificate once approved.
Kind Regards
Inspectorate & Process licensing (OA)
Inspection, Enforcement & Standards Division
Medicines and Healthcare Products Regulatory Agency
10th Floor, 10 South Colonnade, Canary Wharf, London, E14 4PU.
Telephone: 020 3080 6844
gov.uk/mhra
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM